- Main
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
- Benson, Al B;
- D'Angelica, Michael I;
- Abbott, Daniel E;
- Abrams, Thomas A;
- Alberts, Steven R;
- Saenz, Daniel Anaya;
- Are, Chandrakanth;
- Brown, Daniel B;
- Chang, Daniel T;
- Covey, Anne M;
- Hawkins, William;
- Iyer, Renuka;
- Jacob, Rojymon;
- Karachristos, Andrea;
- Kelley, R Kate;
- Kim, Robin;
- Palta, Manisha;
- Park, James O;
- Sahai, Vaibhav;
- Schefter, Tracey;
- Schmidt, Carl;
- Sicklick, Jason K;
- Singh, Gagandeep;
- Sohal, Davendra;
- Stein, Stacey;
- Tian, G Gary;
- Vauthey, Jean-Nicolas;
- Venook, Alan P;
- Zhu, Andrew X;
- Hoffmann, Karin G;
- Darlow, Susan
- et al.
Published Web Location
https://doi.org/10.6004/jnccn.2017.0059Abstract
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-